Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FCER1G |
| Upstream (Parents) |
|---|
| (<<) RHOA → FCER1G |
| (<<) SRGN → FCER1G |
| Downstream (Children) |
|---|
| FCER1G → S100A4 (>>) |
| FCER1G → LOC100306951 (>>) |
| FCER1G → CD300A (>>) |
| FCER1G → LOC391020 (>>) |
| FCER1G → IFITM2 (>>) |
| FCER1G → TSPAN4 (>>) |
| FCER1G → IFI30 (>>) |
| FCER1G → SELM (>>) |
| FCER1G → CLTA (>>) |
| FCER1G → APOL4 (>>) |
| FCER1G → C20orf12 (>>) |
| FCER1G → ING5 (>>) |
| FCER1G → RASD1 (>>) |
| FCER1G → TYROBP (>>) |
| FCER1G → PRELID1 (>>) |
| FCER1G → ZNF709 (>>) |
| FCER1G → CHST11 (>>) |
| FCER1G → IFITM3 (>>) |
| FCER1G → RNASE1 (>>) |
| FCER1G → SNX2 (>>) |
| FCER1G → TACC2 (>>) |
| FCER1G → FCGR3B///FCGR3A (>>) |
| FCER1G → CYBA (>>) |
| FCER1G → C1QC (>>) |
| FCER1G → FCGR2C (>>) |
| FCER1G → GLRX (>>) |
| FCER1G → BMP2K (>>) |
| FCER1G → LOC1518 (>>) |
| FCER1G → SRGN (>>) |
| FCER1G → ALOX5AP (>>) |
| FCER1G → FPR3 (>>) |
